NDUFS7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.305200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.076000E-01
Normal-vs-Stage2
8.225400E-01
Normal-vs-Stage3
2.321800E-01
Normal-vs-Stage4
5.761600E-02
Stage1-vs-Stage2
3.112600E-01
Stage1-vs-Stage3
2.197800E-01
Stage1-vs-Stage4
1.932570E-01
Stage2-vs-Stage3
3.012800E-01
Stage2-vs-Stage4
4.592600E-01
Stage3-vs-Stage4
7.278200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.956000E-01
Normal-vs-AfricanAmerican
5.604400E-01
Normal-vs-Asian
2.397400E-01
Caucasian-vs-AfricanAmerican
6.741200E-01
Caucasian-vs-Asian
7.243000E-03
AfricanAmerican-vs-Asian
4.793900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.826200E-01
Normal-vs-Female
8.480600E-01
Male-vs-Female
5.925400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.238800E-01
Normal-vs-Age(41-60Yrs)
8.659200E-01
Normal-vs-Age(61-80Yrs)
8.974200E-01
Normal-vs-Age(81-100Yrs)
4.865200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.547000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.016400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.315000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.063000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.248400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.827580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.796600E-01
Normal-vs-Daily Drinker
4.382000E-01
Normal-vs-Weekly Drinker
6.540000E-01
Normal-vs-Occasional Drinker
7.633600E-01
Normal-vs-Social Drinker
7.518200E-01
Non Drinker-vs-Daily Drinker
3.402800E-01
Non Drinker-vs-Weekly Drinker
2.017800E-01
Non Drinker-vs-Occasional Drinker
6.528600E-01
Non Drinker-vs-Social Drinker
6.198000E-01
Daily Drinker-vs-Weekly Drinker
9.568400E-01
Daily Drinker-vs-Occasional Drinker
2.651600E-01
Daily Drinker-vs-Social Drinker
2.666800E-01
Weekly Drinker-vs-Occasional Drinker
2.061600E-01
Weekly Drinker-vs-Social Drinker
2.208800E-01
Occasional Drinker-vs-Social Drinker
9.530400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.264600E-01
Normal-vs-Grade 2
8.997800E-01
Normal-vs-Grade 3
9.430200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.810400E-02
Grade 1-vs-Grade 3
8.658100E-02
Grade 1-vs-Grade 4
6.264600E-01
Grade 2-vs-Grade 3
8.125800E-01
Grade 2-vs-Grade 4
8.997800E-01
Grade 3-vs-Grade 4
9.430200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.843000E-01
Normal-vs-NonDiabetic
9.116000E-01
Diabetic-vs-NonDiabetic
3.947200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.563200E-01
Normal-vs-NoPancreatitis
9.706800E-01
Pancreatitis-vs-NoPancreatitis
4.941800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.704800E-01
Normal-vs-N1
7.462800E-01
N0-vs-N1
3.178300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.144600E-01
Normal-vs-TP53-NonMutant
8.040800E-01
TP53-Mutant-vs-TP53-NonMutant
2.480800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
